Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes. - Wikidata - awgldk - TriplyDB

Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.

Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q37269502

about

HDL and glucose metabolism: current evidence and therapeutic potential Reconstituted high-density lipoprotein infusion modulates fatty acid metabolism in patients with type 2 diabetes mellitus Association of Comorbid and Metabolic Factors with Optimal Control of Type 2 Diabetes Mellitus Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle.Effectiveness of a Lifestyle Intervention in Patients with Type 2 Diabetes: The Physical Activity and Nutrition for Diabetes in Alberta (PANDA) Trial The emerging role of HDL in glucose metabolism.Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism.ApoA-I Milano stimulates lipolysis in adipose cells independently of cAMP/PKA activation.Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.

P2860

Q26996502-55F056DB-FCCB-4228-99BB-4AEC7070D5F4 Q34560800-2C33334C-8684-430D-8780-EA9A4202068F Q36667608-44546F38-4841-4E83-AEE5-8A29423D1BDB Q36842237-6549A32F-BF7E-40F0-84A9-B47951E0394D Q37542457-9433A0E8-F32F-4A78-B24E-A01DBA4587A4 Q37978209-AF4BC0E2-9348-40CF-8E30-70E12620F64A Q41548105-F3161828-18BB-4CCB-BECE-FC00D0956D98 Q43160205-83D03F9A-8820-442D-B9BE-1962D12EE91F Q44003021-1F3009EF-18A0-44E8-B40E-F1ECD6739029 Q53099325-F679D4BF-BAEE-448E-8E38-0B3CA91E70AD

P2860

Poor glycemic control is an independent risk factor for low HDL cholesterol in patients with type 2 diabetes.

http://www.wikidata.org/entity/Q37269502

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Poor glycemic control is an in ...... patients with type 2 diabetes.

@en

Poor glycemic control is an in ...... patients with type 2 diabetes.

@nl

type

label

Poor glycemic control is an in ...... patients with type 2 diabetes.

@en

Poor glycemic control is an in ...... patients with type 2 diabetes.

@nl

prefLabel

Poor glycemic control is an in ...... patients with type 2 diabetes.

@en

Poor glycemic control is an in ...... patients with type 2 diabetes.

@nl

P1433

Q37269502-DF4EFF9E-4747-4794-92B0-6E28B1D2647B

P1476

Q37269502-A422E562-F116-4181-8F6E-EF323E356482

P2093

Q37269502-0148F7F6-D342-4ED4-89E3-8F8B3D63C5DB

Q37269502-1F24A078-6047-4755-BAB0-6B8CE1AC22A5

Q37269502-32E74A3F-566D-4846-A8EE-BF42B7F686A2

Q37269502-3C37CC07-2CD1-46B3-8BDA-FBCEBD036E10

Q37269502-71AAC154-1C11-45AE-93CE-1A9E90A8DA76

Q37269502-8A6B7932-30FF-4DAD-BA3E-1EB7CEAAF5A5

P2860

Q37269502-4C1D88CB-06FB-47F8-93D2-FF3D263A83D6

Q37269502-56E92987-A09D-48CA-9FBF-C6502259B3E6

Q37269502-5FE998B1-661E-448F-B598-7CCDE897C4BB

Q37269502-7090A31E-93CA-4250-9780-F4923DFC3B69

Q37269502-7916C74E-A171-414F-872C-7233A07274F7

Q37269502-847E0CF2-E24A-4AD9-AE16-122998218ADF

Q37269502-AD4814FE-CAD4-4D43-9175-76911B16431F

Q37269502-AF692914-A9A8-4754-BAA0-D4E2EE507C39

Q37269502-F9B6E6E1-C828-4B97-B8AD-D14331C4ADFE

Q37269502-FACE71FA-ABF7-45D9-AAD0-3FAD33F78F02

P304

Q37269502-93FF4CEF-E68C-4461-9A79-AB35B1E219B3

P31

Q37269502-68019F27-C7BF-4734-B371-32C83A976269

P356

Q37269502-77843323-C5D5-4D4A-B857-BC78CC81CA79

P407

Q37269502-09FC95B8-58C8-47F4-A29F-A72A99569072

P433

Q37269502-E686FEFA-7722-4F71-AB13-99072C850B89

P478

Q37269502-BA5EC081-3150-4FF1-865A-79209B35F26B

P50

Q37269502-056E4227-9EE6-4336-8053-8E49716467C4

Q37269502-2460E7FD-AB1A-41FD-8786-EC568D288497

Q37269502-C7D51E7E-AB9A-43A0-80B8-2B6DC2051C4B

Q37269502-E80166CE-F5CC-422F-8C1F-CCE41BA2271B

P577

Q37269502-A8CE0BF3-99AD-4C3D-94DB-ECE58BD9F68A

P5875

Q37269502-0489D1B7-1456-40EC-9691-B8EC5A3E46DA

P698

Q37269502-428AB7A4-C0A0-402B-BD4D-869038A76ACF

P921

Q37269502-3A8ABB4D-16BC-45EB-B2F8-D05CE786ADD7

Q37269502-3DC572B1-62F1-4AF2-AB12-364072E5BDD8

P932

Q37269502-D48E6A3E-C403-4834-91F2-EA7152475B32

P356

P1433

P1476

Poor glycemic control is an in ...... patients with type 2 diabetes

@en

P2093

Agostino Gnasso

http://www.w3.org/2001/XMLSchema#string

Alessandra Gatti

http://www.w3.org/2001/XMLSchema#string

Elisabetta Mandosi

http://www.w3.org/2001/XMLSchema#string

Mara Fallarino

http://www.w3.org/2001/XMLSchema#string

Marianna Maranghi

http://www.w3.org/2001/XMLSchema#string

Sebastiano Filetti

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.

Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

Serum high density lipoprotein in diabetic patients.

Standards of medical care in diabetes--2008.

Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.

Association between glycaemic control and serum lipids profile in type 2 diabetic patients: HbA1c predicts dyslipidaemia.

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

P304

1550-1552

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-0256

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Claudio Carallo

Vincenzo Trischitta

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26258414

http://www.w3.org/2001/XMLSchema#string

P698

19487641

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2713640

http://www.w3.org/2001/XMLSchema#string